The Zacks Analyst Blog Highlights Alphabet, AbbVie and The Walt Disney

02.07.25 16:46 Uhr

Werte in diesem Artikel
Aktien

162,60 EUR 5,80 EUR 3,70%

151,10 EUR 1,96 EUR 1,31%

104,46 EUR -0,04 EUR -0,04%

Indizes

PKT PKT

44.484,4 PKT -10,5 PKT -0,02%

22.641,9 PKT 163,8 PKT 0,73%

20.393,1 PKT 190,2 PKT 0,94%

17.423,7 PKT 111,6 PKT 0,64%

3.054,4 PKT 19,6 PKT 0,65%

6.227,4 PKT 29,4 PKT 0,47%

For Immediate ReleaseChicago, IL – July 2, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alphabet Inc. GOOGL, AbbVie Inc. ABBV and The Walt Disney Co. DIS.Here are highlights from Tuesday’s Analyst Blog:Top Stock Reports for Alphabet, AbbVie and Walt DisneyThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc., AbbVie Inc. and The Walt Disney Co.. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today's research reports here >>>Ahead of Wall StreetThe daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.You can read today's AWS here >>> Plenty of Data to Start 2nd Half of 2025Today's Featured Research ReportsShares of Alphabet have underperformed the Zacks Internet - Services industry over the year-to-date period (-7.7% vs. -4.4%). The company's increasing litigation issues are a concern. Intensifying competition from Microsoft and Amazon in cloud computing is a headwind.Nevertheless, Alphabet is riding on strong cloud and search growth. Google Cloud is benefiting from accelerated growth across AI infrastructure, enterprise AI platform Vertex and strong adoption of Generative AI solutions. The company expects capital expenditures in 2025 to be relatively higher than in 2024, aimed at building technical infrastructure, primarily for servers, followed by data centers and networking.Alphabet's dominant position in the search engine market is a strong growth driver. In first-quarter 2025, GOOGL saw continued double-digit revenue growth in Search. Alphabet surpassed 270 million paid subscriptions with YouTube and Google One as key drivers.(You can read the full research report on Alphabet here >>>)AbbVie's shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the year-to-date period (+6.2% vs. -0.6%). The company has successfully navigated Humira's loss of exclusivity (LOE) by launching two other successful new immunology medicines, Skyrizi and Rinvoq, which are performing extremely well -- bolstered by approvals in new indications and should support top-line growth in the next few years.AbbVie has several early/mid-stage candidates that have the potential to drive long-term growth. It expects to return to robust revenue growth in 2025, which is just the second year following the U.S. Humira LOE. AbbVie has been on an acquisition spree, mainly in its core space of immunology.However, the company faces several near-term headwinds like Humira LOE impact, increasing competitive pressure on Imbruvica and slowing sales of its aesthetics franchise.(You can read the full research report on AbbVie here >>>)Shares of Walt Disney have gained +11.5% over the year-to-date period against the Zacks Media Conglomerates industry's gain of +14.7%. The company is benefiting from strength in Domestic Parks & Experiences revenues driven by growth at domestic parks, Disney Vacation Club and Disney Cruise Line, partially offset by decline at international locations includingShanghai Disney Resort and Hong Kong Disneyland Resort. In Entertainment, DIS expects double-digit segment operating income growth in fiscal 2025. The Zacks analyst expects fiscal 2025 net sales to increase 3.7% from fiscal 2024.However, Disney+'s profitability is expected to be hurt by higher investments in content, which will also increase programming and production costs in the Entertainment segment. For fiscal Q3, Disney expects a modest increase in its Disney+ subscriber base on a sequential basis. Disney's declining ad revenues is an overhang. The company's leveraged balance sheet remains a concern.(You can read the full research report on Walt Disney here >>>)Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.com                                      https://www.zacks.com                                                 Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Walt Disney Company (DIS): Free Stock Analysis Report AbbVie Inc. (ABBV): Free Stock Analysis Report Alphabet Inc. (GOOGL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: AbbVie und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf AbbVie

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf AbbVie

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Alphabet C (ex Google)

Wer­bung

Analysen zu Alphabet C (ex Google)

DatumRatingAnalyst
21.05.2025Alphabet C (ex Google) KaufenDZ BANK
25.04.2025Alphabet C (ex Google) KaufenDZ BANK
05.02.2025Alphabet C (ex Google) HaltenDZ BANK
23.12.2024Alphabet C (ex Google) OverweightJP Morgan Chase & Co.
30.10.2024Alphabet C (ex Google) KaufenDZ BANK
DatumRatingAnalyst
21.05.2025Alphabet C (ex Google) KaufenDZ BANK
25.04.2025Alphabet C (ex Google) KaufenDZ BANK
23.12.2024Alphabet C (ex Google) OverweightJP Morgan Chase & Co.
30.10.2024Alphabet C (ex Google) KaufenDZ BANK
30.10.2024Alphabet C (ex Google) KaufenDZ BANK
DatumRatingAnalyst
05.02.2025Alphabet C (ex Google) HaltenDZ BANK
11.01.2024Alphabet C (ex Google) NeutralUBS AG
29.05.2019Alphabet C (ex Google) HoldPivotal Research Group
26.10.2018Alphabet C (ex Google) HoldCanaccord Adams
17.08.2018Alphabet C (ex Google) HoldMorningstar
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Alphabet C (ex Google) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen